OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 Magnesium Glycinate safety to take
  2. 2 What is the problem in people with kidney disease

Answered on this page ↓

What is the problem in people with kidney disease

Nov 20, 2026 · 5 sources used · OpenNeedle synthesis
In kidney disease, magnesium is a two-sided problem: the kidneys lose the ability to dump excess, so levels can climb, but poor diet, acid-suppressing drugs, and dialysis can also push them too low.

The core issue is that healthy kidneys filter out what you don't need. As kidney function falls, that exit route narrows. In a study of 156 people with moderate to severe kidney disease, high magnesium got more common as kidney function worsened: about 5 in 100 at stage G3, about 14 in 100 at G4, and about 30 in 100 at G5 [1]. Low magnesium also appeared, rising to about 15 in 100 at G5 [1]. So the same person can swing either way, and neither direction is benign.

CKD stageHigh magnesiumLow magnesium
G35.13%0%
G413.64%6.82%
G530.14%15.07%

A separate problem is that the body holds onto magnesium in places blood tests don't show. In 17 dialysis patients on low-magnesium dialysate for up to 60 months, red-cell magnesium stayed high (4.48 vs 2.87 mmol/L in controls) and bone magnesium was elevated (1.58 vs 0.98 g/L), even though blood levels looked normal [5]. That means a normal serum magnesium can hide a tissue surplus.

The other direction matters too. Long-term proton pump inhibitors (omeprazole and similar) cause low magnesium by raising gut pH and blocking absorption through channels called TRPM6 [3]. In kidney transplant recipients, PPI users had roughly double the odds of low magnesium, and the effect was stronger at higher doses [4]. One dialysis patient on omeprazole developed severe low magnesium (0.30 mmol/L) with low potassium, low calcium, and heart-rhythm changes on ECG, all reversing after the drug was stopped and magnesium replaced [2].

What this evidence does not settle: whether taking extra magnesium glycinate is safe or harmful at any given stage of kidney disease. No trial here tested supplementation in kidney patients. The mechanism cuts both ways, and the right answer depends on your blood level, your stage, and your other drugs. That is a conversation with a nephrologist, not a label dose.

My call: if you have kidney disease, do not take magnesium glycinate on your own; get your magnesium and kidney function checked first, because the risk runs in both directions and the tissue level can be high while the blood test looks fine. Confidence: moderate on the mechanism, low on any specific dose.

Keep digging

Sources used 5

  1. Impact of Serum Magnesium Levels on Mineral-Bone Metabolism in Non-Dialysis-Dependent Chronic Kidney Disease Risk Management and Healthcare Policy (2025) Thin

    A retrospective single-center study of 156 non-dialysis CKD patients (G3–G5) found that serum magnesium levels tend to rise with CKD stage and that magnesium status is associated with calcium-related mineral metabolism markers, with hypomagnesemia and hypermagnesemia becoming mo…

    DOI: 10.2147/rmhp.s516474
  2. Hypomagnesemia with Secondary Electrolyte Disturbances in a Hemodialysis Patient on Omeprazole Following Gi Infection: A Case Report with A Brief Literature Review Scholars Journal of Medical Case Reports (2025) other Strong

    A 70-year-old hemodialysis patient on omeprazole developed severe symptomatic hypomagnesemia with hypokalemia, hypocalcemia, and QT prolongation after gastrointestinal infection; omeprazole withdrawal and magnesium repletion were followed by symptom and electrolyte normalization.

    DOI: 10.36347/sjmcr.2025.v13i09.006
  3. Hypomagnesemia as an Underrecognized Adverse Effect of Long-Term Proton Pump Inhibitor Therapy: Literature review Journal of Education, Health and Sport (2026) narrative review Strong

    This narrative review consolidates evidence that long-term proton pump inhibitor therapy causes hypomagnesemia by raising intestinal luminal pH and impairing TRPM6/TRPM7-mediated magnesium absorption, and argues that routine magnesium monitoring in long-term PPI users is warrant…

    DOI: 10.12775/jehs.2026.95.73646
  4. Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients Journal of Clinical Medicine (2019) Thin

    Chronic proton-pump inhibitor use in kidney transplant recipients is independently linked to lower plasma and urinary magnesium and a higher risk of hypomagnesaemia, with stronger effects at higher PPI doses, suggesting reduced intestinal magnesium absorption rather than renal w…

    DOI: 10.3390/jcm8122162
  5. The Effect of Low Magnesium Dialysate on Plasma, Ultrafiltrable, Erythrocyte and Bone Magnesium Concentrations from Patients on Maintenance Haemodialysis Nephron (2008) primary study Strong

    In 17 maintenance haemodialysis patients, 60 months of low-magnesium dialysate did not reduce elevated erythrocyte or bone magnesium, despite an acute dialysis-induced fall in plasma and ultrafiltrable magnesium.

    DOI: 10.1159/000180413

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →